cell-free DNA
Liquid Biopsy Startup Aitiologic Launches With €2.5M in Private-Public Funding
The company said it is commercializing a cell-free DNA assay based on a proprietary technology developed by a company cofounder at Siemens Healthineers.
Researchers are planning a clinical trial after four metastatic FGFR2 fusion-positive pancreatic cancer patients responded to FGFR-directed therapy.
Lung Cancer Groups Seek Public Comment on Updated Biomarker Testing Guidelines
Updated guidelines recommend certain biomarker tests for early- and late-stage lung cancer at the time of diagnosis.
BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring Test
Premium
The company said it has seen faster-than-expected adoption after launching its tests last year and is approaching reimbursement milestones as it continues to build data.
Johns Hopkins Team Debuts Method for Genome-Wide Detection of Cancer-Linked Repeat Sequences
Premium
The approach allows a much broader survey and quantification of alterations to repeat elements of the genome, which authors found could help detect cancers.